Price
No data yet.
Social Signal Score
50
5d
50
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1
Company Profile
- CEO
- Jinzi J. Wu
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 202
- Beta
- 0.39
- Country
- HK
Quote
Day Range
—
52-Week Range
—
Volume
—
Market Cap
—
50-Day Avg
—
200-Day Avg
—
Prev Close
—
Open
—
Valuation & Ratios
P/E Ratio
—
EPS
—
P/B Ratio
—
P/S Ratio
—
Debt/Equity
—
Current Ratio
—
Dividend Yield
—
Gross Margin
—
Returns & Efficiency
Return on Equity
—
Return on Assets
—
FCF Yield
—
EV/EBITDA
—
Valuation
1672.HKhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Sep 7Sep 7
Social Signal Score
50
5d
50
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1
Mentions (1)
- Newsprnewswire.com·8h ago·Neutral
Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that, the ordinary shares of the Company (the "Shares"), which trade on The Stock
View source ↗